Publicacions (90) Publicacions de Estíbaliz Alegre Martínez

filter_list

2026

  1. The analytical impact of extracellular vesicles PSA on different commercial total PSA measurement methods

    Biochemia medica, Vol. 36, Núm. 1, pp. 010703

2025

  1. Clinical utility of personalized reference intervals for CEA in the early detection of oncologic disease

    Clinical Chemistry and Laboratory Medicine, Vol. 63, Núm. 2, pp. 376-386

  2. Routine data analysis for moderate hemolysis interference correction in neuron specific enolase quantification

    Biochemia Medica, Vol. 35, Núm. 2

  3. Screening with Metoclopramide Test to Reduce Unnecessary Pituitary Magnetic Resonance Studies in Moderate Hyperprolactinemia

    The journal of applied laboratory medicine, Vol. 10, Núm. 1, pp. 48-58

  4. Systemic messenger RNA replacement therapy is effective in a novel clinically relevant model of acute intermittent porphyria developed in non-human primates

    Gut, Vol. 74, Núm. 2, pp. 270-283

  5. Tracking CTC Dynamics: Trop2 and EpCAM in Metastatic Breast Cancer Progression

    Cancers

  6. Utilidad del PSA en vesículas extracelulares como biomarcador de seguimiento en el cáncer de próstata

    Advances in Laboratory Medicine, Vol. 6, Núm. 4, pp. 450-457

  7. Utility of PSA in extracellular vesicles as a follow-up biomarker in prostate cancer

    Advances in Laboratory Medicine / Avances en Medicina de Laboratorio, Vol. 6, Núm. 4, pp. 442-449

2024

  1. Extracellular vesicles in cancer: challenges and opportunities for clinical laboratories

    Critical Reviews in Clinical Laboratory Sciences, Vol. 61, Núm. 6, pp. 435-457

  2. Tracking dynamic evolution of low- and intermediate-risk differentiated thyroid cancer: Identification of individuals at risk of recurrence

    Clinical Endocrinology, Vol. 101, Núm. 3, pp. 286-294

2023

  1. Clinical implications of changing thyroglobulin and antithyroglobulin antibodies analytical methods in the follow-up of patients with differentiated thyroid carcinoma

    Clinica Chimica Acta, Vol. 548

  2. MAPK inhibitors dynamically affect melanoma release of immune NKG2D-ligands, as soluble protein and extracellular vesicle-associated

    Frontiers in Cell and Developmental Biology, Vol. 10

  3. PSA reactivity in extracellular microvesicles to commercial immunoassays

    Clinica Chimica Acta, Vol. 543

2022

  1. Impact of ultra-low temperature long-term storage on the preanalytical variability of twenty-one common biochemical analytes

    Clinical Chemistry and Laboratory Medicine, Vol. 60, Núm. 7, pp. 1003-1010

  2. Modification of baseline status to improve breath tests performance

    Scientific Reports, Vol. 12, Núm. 1

  3. Questionable High Free T4 Concentrations: When Confirming against an Alternative Method Is Not Enough

    Clinical chemistry, Vol. 68, Núm. 9, pp. 1128-1132

2021

  1. Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients

    Cytokine, Vol. 141

  2. Exosomes in lung cancer: Actors and heralds of tumor development

    Cancers, Vol. 13, Núm. 17

  3. mRNA-based therapy in a rabbit model of variegate porphyria offers new insights into the pathogenesis of acute attacks

    Molecular Therapy - Nucleic Acids, Vol. 25, pp. 207-219

2020

  1. Estudio del test de tolerancia a lactosa como alternativa a test de hidrógeno espirado en el estudio de la malabsorción de lactosa

    Advances in Laboratory Medicine, Vol. 1, Núm. 4